126 related articles for article (PubMed ID: 31342940)
1. Range and dose verification in proton therapy using proton-induced positron emitters and recurrent neural networks (RNNs).
Liu C; Li Z; Hu W; Xing L; Peng H
Phys Med Biol; 2019 Sep; 64(17):175009. PubMed ID: 31342940
[TBL] [Abstract][Full Text] [Related]
2. Technical Note: Machine learning approaches for range and dose verification in proton therapy using proton-induced positron emitters.
Li Z; Wang Y; Yu Y; Fan K; Xing L; Peng H
Med Phys; 2019 Dec; 46(12):5748-5757. PubMed ID: 31529506
[TBL] [Abstract][Full Text] [Related]
3. A machine learning framework with anatomical prior for online dose verification using positron emitters and PET in proton therapy.
Hu Z; Li G; Zhang X; Ye K; Lu J; Peng H
Phys Med Biol; 2020 Sep; 65(18):185003. PubMed ID: 32460246
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of patient-specific dose verification in proton therapy utilizing positron emission tomography (PET) and generative adversarial network (GAN).
Ma S; Hu Z; Ye K; Zhang X; Wang Y; Peng H
Med Phys; 2020 Oct; 47(10):5194-5208. PubMed ID: 32772377
[TBL] [Abstract][Full Text] [Related]
5. Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy.
Frey K; Unholtz D; Bauer J; Debus J; Min CH; Bortfeld T; Paganetti H; Parodi K
Phys Med Biol; 2014 Oct; 59(19):5903-19. PubMed ID: 25211629
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of range verification based on proton-induced acoustic signals and recurrent neural network.
Yao S; Hu Z; Zhang X; Lou E; Liang Z; Wang Y; Peng H
Phys Med Biol; 2020 Nov; 65(21):215017. PubMed ID: 32726760
[TBL] [Abstract][Full Text] [Related]
7. Further investigation of 3D dose verification in proton therapy utilizing acoustic signal, wavelet decomposition and machine learning.
Yao S; Hu Z; Xie Q; Yang Y; Peng H
Biomed Phys Eng Express; 2021 Nov; 8(1):. PubMed ID: 34768245
[TBL] [Abstract][Full Text] [Related]
8. Machine learning based oxygen and carbon concentration derivation using dual-energy CT for PET-based dose verification in proton therapy.
Liu Y; Zhou L; Peng H
Med Phys; 2022 May; 49(5):3347-3360. PubMed ID: 35246842
[TBL] [Abstract][Full Text] [Related]
9. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
10. Fast spot-scanning proton dose calculation method with uncertainty quantification using a three-dimensional convolutional neural network.
Nomura Y; Wang J; Shirato H; Shimizu S; Xing L
Phys Med Biol; 2020 Oct; 65(21):215007. PubMed ID: 32604078
[TBL] [Abstract][Full Text] [Related]
11. Use of short-lived positron emitters for in-beam and real-time β
Bongrand A; Busato E; Force P; Martin F; Montarou G
Phys Med; 2020 Jan; 69():248-255. PubMed ID: 31918377
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the physical potential of proton beam range verification with PET/CT.
Knopf A; Parodi K; Paganetti H; Cascio E; Bonab A; Bortfeld T
Phys Med Biol; 2008 Aug; 53(15):4137-51. PubMed ID: 18635897
[TBL] [Abstract][Full Text] [Related]
13. The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.
España S; Paganetti H
Phys Med Biol; 2010 Dec; 55(24):7557-71. PubMed ID: 21098912
[TBL] [Abstract][Full Text] [Related]
14. Beam-on imaging of short-lived positron emitters during proton therapy.
Buitenhuis HJT; Diblen F; Brzezinski KW; Brandenburg S; Dendooven P
Phys Med Biol; 2017 Jun; 62(12):4654-4672. PubMed ID: 28379155
[TBL] [Abstract][Full Text] [Related]
15. PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.
Parodi K; Paganetti H; Cascio E; Flanz JB; Bonab AA; Alpert NM; Lohmann K; Bortfeld T
Med Phys; 2007 Feb; 34(2):419-35. PubMed ID: 17388158
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of quasi-prompt PET-based range verification in proton therapy.
Ozoemelam I; van der Graaf E; van Goethem MJ; Kapusta M; Zhang N; Brandenburg S; Dendooven P
Phys Med Biol; 2020 Dec; 65(24):245013. PubMed ID: 32650323
[TBL] [Abstract][Full Text] [Related]
17. Deep Convolution Neural Network (DCNN) Multiplane Approach to Synthetic CT Generation From MR images-Application in Brain Proton Therapy.
Spadea MF; Pileggi G; Zaffino P; Salome P; Catana C; Izquierdo-Garcia D; Amato F; Seco J
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):495-503. PubMed ID: 31271823
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.
Almeida IP; Schyns LEJR; Vaniqui A; van der Heyden B; Dedes G; Resch AF; Kamp F; Zindler JD; Parodi K; Landry G; Verhaegen F
Phys Med Biol; 2018 May; 63(11):115008. PubMed ID: 29616662
[TBL] [Abstract][Full Text] [Related]
20. Extension of the ML-EM algorithm for dose estimation using PET in proton therapy: application to an inhomogeneous target.
Masuda T; Nishio T; Sano A; Karasawa K
Phys Med Biol; 2020 Sep; 65(18):185001. PubMed ID: 32485687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
